Gene Salkind, Director, Ten Percent Owner at Mobiquity Technologies, holds 316.74K shares in Coeptis Therapeutics Holdings (Ticker: COEP), holds 448.54K shares in Mobiquity Technologies (Ticker: MOBQ), holds 2.48M shares in Upexi (Ticker: UPXI). Most recently, Gene Salkind Bought ― shares of Coeptis Therapeutics Holdings on Jan 09, 2024 for an estimated value of 8.00K.
Gene Salkind latest transaction was an Informative Buy of $8.00K.
What was Gene Salkind's most profitable transaction?
Gene Salkind’s most profitable transaction was an Informative Buy of UPXI stock on April 1, 2022. The return on the trade was -24.10%.
What is Gene Salkind's role in Mobiquity Technologies?
Gene Salkind's role in Mobiquity Technologies is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.